Ervington Investments

Ervington Investments

Ervington Investments

Latest investments Show all
$20,000,000
Venture capital (Series C)
Avelas Biosciences
$51,200,000
Private equity
TransMedics
Team Size
1–10
Employees
Past year's investments

Ervington Investments participated in fewer than 3 rounds over the past year

Latest rounds
  • Avelas Biosciences: Venture capital (Series C) ($20M)
  • TransMedics: Private equity ($51.2M)
  • Via: Venture capital (Series C) ($100M)